Peer-reviewedCC BYOpen forum infectious diseases
Long-Acting Injectable Antiretroviral Therapy as a Catalyst for Engagement in Opioid Use Disorder Treatment Among People With HIV Who Use Drugs
Related
- Long-acting Injectable Antiretroviral Therapy in South African Adolescents and Young Adults – Week 48 results from the AFINAty Study
- Efficacy and safety of long-acting injectable aripiprazole in bipolar disorder: a multinational real-world target trial emulation
- High Initiation but Suboptimal Completion of Tuberculosis-Preventive Treatment Among People Living With HIV on Antiretroviral Therapy, Persistent Tuberculosis Incidence, and Programmatic Implications: Findings From a 2-Year Multicountry Cohort Study
- Prevalence of neural tube defects and major external structural abnormalities by antiretroviral treatment regimen in Botswana in 2014–22: a birth outcomes surveillance study
- Pathways to medication adherence: a configurational analysis of psychiatric symptoms and medication attitude in patients with schizophrenia spectrum disorder receiving long-acting injectable antipsychotics.
BibTeX
@article{anon2026longacting,
title = {{Long-Acting Injectable Antiretroviral Therapy as a Catalyst for Engagement in Opioid Use Disorder Treatment Among People With HIV Who Use Drugs}},
journal = {Open forum infectious diseases},
year = {2026},
month = oct,
url = {https://europepmc.org/article/PMC/PMC13728585},
note = {CC BY},
}
RIS
TY - JOUR
TI - Long-Acting Injectable Antiretroviral Therapy as a Catalyst for Engagement in Opioid Use Disorder Treatment Among People With HIV Who Use Drugs
PY - 2026
DA - 2026/10/24
JO - Open forum infectious diseases
UR - https://europepmc.org/article/PMC/PMC13728585
SN - 2328-8957
ER -